| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7425333 |
Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7 |
Sep. 16, 2008 |
| 7425332 |
Treatment of autoimmune conditions with Copolymer 1 and related Copolymers |
Sep. 16, 2008 |
| 7425217 |
System and method for inhibiting cellular proliferation with tachykinins |
Sep. 16, 2008 |
| 7423021 |
Peptidic thrombin inhibitors |
Sep. 9, 2008 |
| 7423020 |
Treatment of mood disorders by administration of SMR1 |
Sep. 9, 2008 |
| 7423017 |
Method for treating cartilage disorders |
Sep. 9, 2008 |
| 7423013 |
Protein formulation |
Sep. 9, 2008 |
| 7423012 |
Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
Sep. 9, 2008 |
| 7423011 |
Therapeutic chemokine receptor antagonists |
Sep. 9, 2008 |
| 7423010 |
Nonporous microparticle-prodrug conjugates for treatment of infection |
Sep. 9, 2008 |
| 7423009 |
Method for treatment of kidney diseases |
Sep. 9, 2008 |
| 7422753 |
Methods for treating trichotillomania |
Sep. 9, 2008 |
| 7422752 |
Mutant forms of EtxB and CtxB and their use as carriers |
Sep. 9, 2008 |
| 7419952 |
Use of exendins and agonists thereof to treat diabetes |
Sep. 2, 2008 |
| 7419951 |
Method of reducing adipocyte growth in a subject in need thereof by administration of natriuretic peptide receptor C inhibitors |
Sep. 2, 2008 |
| 7419950 |
Methods of inhibiting ectopic calcification |
Sep. 2, 2008 |
| 7419949 |
Single-dose administration of factor VIIa |
Sep. 2, 2008 |
| 7419795 |
Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
Sep. 2, 2008 |
| 7419682 |
Poultry feed containing plasma |
Sep. 2, 2008 |
| 7419676 |
Activatable recombinant neurotoxins |
Sep. 2, 2008 |
| 7419663 |
Treatment of complement-associated disorders |
Sep. 2, 2008 |
| 7419600 |
Method for purifying a branched water-soluble polymer |
Sep. 2, 2008 |
| 7417028 |
Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions |
Aug. 26, 2008 |
| 7417025 |
Use of poly-.alpha.2,8-sialic acid mimetic peptides to modulate NCAM functions |
Aug. 26, 2008 |
| 7417022 |
Compounds and compositions for delivering active agents |
Aug. 26, 2008 |
| 7417021 |
Biologically active conjugate of a biopolymer and therapeutic agent |
Aug. 26, 2008 |
| 7416724 |
Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
Aug. 26, 2008 |
| 7414169 |
Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
Aug. 19, 2008 |
| 7414027 |
Peptide antagonists of vascular endothelial growth factor |
Aug. 19, 2008 |
| 7414024 |
Proteins with IL-6 inhibiting activity |
Aug. 19, 2008 |
| 7414023 |
Peptide ligands for prostate specific antigen |
Aug. 19, 2008 |
| 7414022 |
Factor VII or VIIa-like molecules |
Aug. 19, 2008 |
| 7414021 |
Method and composition for restoration of age related tissue loss in the face or selected areas of the body |
Aug. 19, 2008 |
| 7414020 |
Human checkpoint kinase, hCDS1, compositions and methods |
Aug. 19, 2008 |
| 7414019 |
FGF-8 methods of use |
Aug. 19, 2008 |
| 7413753 |
Calcium phosphate delivery vehicles for osteoinductive proteins |
Aug. 19, 2008 |
| 7413743 |
Active immunization using a siderophore receptor protein |
Aug. 19, 2008 |
| 7413742 |
Clostridial toxin derivatives and methods for treating pain |
Aug. 19, 2008 |
| 7410945 |
Treatment of inflammatory bowel disease |
Aug. 12, 2008 |
| 7410944 |
Depression gene |
Aug. 12, 2008 |
| 7410943 |
Imaging agents |
Aug. 12, 2008 |
| 7410645 |
Moraxella (Branhamella) catarrhalis antigens |
Aug. 12, 2008 |
| 7407944 |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
Aug. 5, 2008 |
| 7407932 |
Methods for glucagon suppression using modified exendins |
Aug. 5, 2008 |
| 7407931 |
Method of treating Crohn's Disease using sargramostim |
Aug. 5, 2008 |
| 7407929 |
Leptin peptide antagonists |
Aug. 5, 2008 |
| 7407659 |
Methods of diagnosing pre-eclampsia or eclampsia |
Aug. 5, 2008 |
| 7405200 |
Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
Jul. 29, 2008 |
| 7405195 |
Cosmetic compositions |
Jul. 29, 2008 |
| 7405194 |
Therapeutic agents and methods of use thereof for the treatment of melanoma |
Jul. 29, 2008 |
|
|
|
